|
Volumn 25, Issue 6, 2000, Pages 623-626
|
Undertreatment in secondary prevention of patients with coronary heart disease after revascularization;Unterversorgung in der Sekundärprävention bei Patienten mit koronarer Herzerkrankung nach Revaskularisation.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
AFTERCARE;
ARTICLE;
CORONARY ARTERY DISEASE;
EVIDENCE BASED MEDICINE;
GERMANY;
HEALTH CARE QUALITY;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
MORTALITY;
POSTOPERATIVE COMPLICATION;
RECURRENT DISEASE;
SURVIVAL RATE;
ADRENERGIC BETA-ANTAGONISTS;
AFTERCARE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTICHOLESTEREMIC AGENTS;
ASPIRIN;
CORONARY DISEASE;
EVIDENCE-BASED MEDICINE;
GERMANY;
HUMANS;
MYOCARDIAL REVASCULARIZATION;
POSTOPERATIVE COMPLICATIONS;
QUALITY ASSURANCE, HEALTH CARE;
RECURRENCE;
SURVIVAL RATE;
|
EID: 0034280651
PISSN: 03409937
EISSN: None
Source Type: Journal
DOI: 10.1007/PL00001975 Document Type: Article |
Times cited : (8)
|
References (0)
|